Concepedia

Publication | Open Access

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

DOIFull Paper Access

577

Citations

22

References

2018

Year

Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman, Krikor Bornazyan, Nicholas Reese, T. Wang, Paul Coluzzi, Blanca Ledezma, Melody Mendenhall, J.S. Hunt,
Journal of Thoracic Oncology

References

YearCitations

Page 1